Company: MYSEW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004290
Chunk: 169

Company: Myseum, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 169
---
on the Nasdaq Capital Market is subject to us meeting applicable listing criteria.

We are currently listed on the Nasdaq Stock Market,
LLC (“Nasdaq”), a national securities exchange. The Nasdaq requires companies desiring to list their common stock to meet
certain listing criteria including total number of shareholders: minimum stock price, total value of public float, and in some cases
total shareholders’ equity and market capitalization. Our failure to meet such applicable listing criteria could prevent us from
listing our common stock on the Nasdaq. In the event we are unable to have our shares traded on Nasdaq, our common stock could potentially
trade on the OTCQX or the OTCQB, each of which is generally considered less liquid and more volatile than the Nasdaq. Our failure to
have our shares traded on the Nasdaq could make it more difficult for you to trade our shares, could prevent our common stock trading
on a frequent and liquid basis and could result in the value of our Common Stock being less than it would be if we were able to list
our shares on the Nasdaq.

Our principal stockholders and management
own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.

Our directors, executive officers and each of
our stockholders who owned greater than 5% of our outstanding Common Stock beneficially, as of March 28, 2025, own approximately 7.7%
of our common stock outstanding. Accordingly, these stockholders have and will continue to have significant influence over the outcome
of corporate actions requiring stockholder approval, including the election of directors, a merger, the consolidation or sale of all
or substantially all of our assets or any other significant corporate transaction. The interests of these stockholders may not be the
same as or may even conflict with our other investors’ interests. For example, these stockholders could delay or prevent a change
in control of us, even if such a change in control would benefit our other stockholders, which could deprive our stockholders of an opportunity
to receive a premium for their Common Stock as part of a sale of the Company or our assets. The significant concentration of stock ownership
may negatively impact the value of our Common Stock due to potential investors’ perception that conflicts of interest may exist
or arise.

There are risks associated with the completion
of the proposed spin-off of our Habytat platform business.

As previously announced, we plan to spin-off
the H